BIOMAT Database Logo BIOMAT Database Logo

Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases. 2019

Asghar Fallah, and Ali Sadeghinia, and Houman Kahroba, and Amin Samadi, and Hamid Reza Heidari, and Behzad Bradaran, and Sirous Zeinali, and Ommoleila Molavi
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

Angiogenesis is a critical step in the progression of almost all human malignancies and some other life-threatening diseases. Anti-angiogenic therapy is a novel and effective approach for treatment of angiogenesis-dependent diseases such as cancer, diabetic retinopathy, and age-related macular degeneration. In this article, we will review the main strategies developed for anti-angiogenic therapies beside their clinical applications, the major challenges, and the latest advances in the development of anti-angiogenesis-based targeted therapies.

UI MeSH Term Description Entries
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D042461 Vascular Endothelial Growth Factor A The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced. Vascular Endothelial Growth Factor,Vascular Endothelial Growth Factor-A,GD-VEGF,Glioma-Derived Vascular Endothelial Cell Growth Factor,VEGF,VEGF-A,Vascular Permeability Factor,Vasculotropin,Glioma Derived Vascular Endothelial Cell Growth Factor,Permeability Factor, Vascular
D043925 Angiogenesis Inducing Agents Agents that induce or stimulate PHYSIOLOGIC ANGIOGENESIS or PATHOLOGIC ANGIOGENESIS. Angiogenesis Inducers,Angiogenesis Effect,Angiogenesis Effects,Angiogenesis Factor,Angiogenesis Stimulating Agents,Angiogenesis Stimulators,Angiogenic Factor,Tumor Angiogenic Factor,Agents, Angiogenesis Inducing,Agents, Angiogenesis Stimulating,Angiogenic Factor, Tumor,Effect, Angiogenesis,Effects, Angiogenesis,Factor, Angiogenesis,Factor, Angiogenic,Factor, Tumor Angiogenic,Inducers, Angiogenesis,Inducing Agents, Angiogenesis,Stimulating Agents, Angiogenesis,Stimulators, Angiogenesis
D020533 Angiogenesis Inhibitors Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. Angiogenesis Factor Inhibitor,Angiogenesis Inhibitor,Angiogenetic Antagonist,Angiogenetic Inhibitor,Angiogenic Antagonist,Angiogenic Antagonists,Angiogenic Inhibitor,Angiostatic Agent,Angiostatic Agents,Anti-Angiogenetic Agent,Anti-Angiogenic Drug,Anti-Angiogenic Drugs,Antiangiogenic Agent,Neovascularization Inhibitor,Neovascularization Inhibitors,Angiogenesis Factor Inhibitors,Angiogenetic Antagonists,Angiogenetic Inhibitors,Angiogenic Inhibitors,Antagonists, Angiogenic,Anti-Angiogenesis Effect,Anti-Angiogenesis Effects,Anti-Angiogenetic Agents,Antiangiogenesis Effect,Antiangiogenesis Effects,Antiangiogenic Agents,Inhibitors, Angiogenesis,Inhibitors, Angiogenetic,Inhibitors, Angiogenic,Inhibitors, Neovascularization,Agent, Angiostatic,Agent, Anti-Angiogenetic,Agent, Antiangiogenic,Agents, Angiostatic,Agents, Anti-Angiogenetic,Agents, Antiangiogenic,Antagonist, Angiogenetic,Antagonist, Angiogenic,Antagonists, Angiogenetic,Anti Angiogenesis Effect,Anti Angiogenesis Effects,Anti Angiogenetic Agent,Anti Angiogenetic Agents,Anti Angiogenic Drug,Anti Angiogenic Drugs,Drug, Anti-Angiogenic,Drugs, Anti-Angiogenic,Effect, Anti-Angiogenesis,Effect, Antiangiogenesis,Effects, Anti-Angiogenesis,Effects, Antiangiogenesis,Factor Inhibitor, Angiogenesis,Factor Inhibitors, Angiogenesis,Inhibitor, Angiogenesis,Inhibitor, Angiogenesis Factor,Inhibitor, Angiogenetic,Inhibitor, Angiogenic,Inhibitor, Neovascularization,Inhibitors, Angiogenesis Factor

Related Publications

Asghar Fallah, and Ali Sadeghinia, and Houman Kahroba, and Amin Samadi, and Hamid Reza Heidari, and Behzad Bradaran, and Sirous Zeinali, and Ommoleila Molavi
Molecular pathways and the hope of targeting angiogenesis.
September 2007, Nature clinical practice. Urology,
Asghar Fallah, and Ali Sadeghinia, and Houman Kahroba, and Amin Samadi, and Hamid Reza Heidari, and Behzad Bradaran, and Sirous Zeinali, and Ommoleila Molavi
Tumor angiogenesis: molecular pathways and therapeutic targets.
November 2011, Nature medicine,
Asghar Fallah, and Ali Sadeghinia, and Houman Kahroba, and Amin Samadi, and Hamid Reza Heidari, and Behzad Bradaran, and Sirous Zeinali, and Ommoleila Molavi
THERAPEUTIC TARGETING OF MOLECULAR PATHWAYS IN COLORECTAL CANCER.
May 2022, Experimental oncology,
Asghar Fallah, and Ali Sadeghinia, and Houman Kahroba, and Amin Samadi, and Hamid Reza Heidari, and Behzad Bradaran, and Sirous Zeinali, and Ommoleila Molavi
Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.
October 2000, Academic radiology,
Asghar Fallah, and Ali Sadeghinia, and Houman Kahroba, and Amin Samadi, and Hamid Reza Heidari, and Behzad Bradaran, and Sirous Zeinali, and Ommoleila Molavi
Therapeutic targeting of STAT pathways in CNS autoimmune diseases.
January 2013, JAK-STAT,
Asghar Fallah, and Ali Sadeghinia, and Houman Kahroba, and Amin Samadi, and Hamid Reza Heidari, and Behzad Bradaran, and Sirous Zeinali, and Ommoleila Molavi
Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer.
November 2021, Advanced drug delivery reviews,
Asghar Fallah, and Ali Sadeghinia, and Houman Kahroba, and Amin Samadi, and Hamid Reza Heidari, and Behzad Bradaran, and Sirous Zeinali, and Ommoleila Molavi
Metabolic pathways involved in retinal angiogenesis: Molecular mechanisms and therapeutic targets.
January 2026, Experimental eye research,
Asghar Fallah, and Ali Sadeghinia, and Houman Kahroba, and Amin Samadi, and Hamid Reza Heidari, and Behzad Bradaran, and Sirous Zeinali, and Ommoleila Molavi
Targeting hypoxia signaling pathways in angiogenesis.
January 2024, Frontiers in physiology,
Asghar Fallah, and Ali Sadeghinia, and Houman Kahroba, and Amin Samadi, and Hamid Reza Heidari, and Behzad Bradaran, and Sirous Zeinali, and Ommoleila Molavi
Molecular targeting of angiogenesis.
March 2004, Biochimica et biophysica acta,
Asghar Fallah, and Ali Sadeghinia, and Houman Kahroba, and Amin Samadi, and Hamid Reza Heidari, and Behzad Bradaran, and Sirous Zeinali, and Ommoleila Molavi
Targeting Cell Death Pathways for Therapeutic Intervention in Kidney Diseases.
May 2016, Seminars in nephrology,
Copied contents to your clipboard!